Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sushmita Sinha

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|November 16, 2020
IL-12-Induced Immune Suppressive Deficit During CD8+ T-Cell DifferentiationPranav S Renavikar, Sushmita Sinha, Ashley A Brate, et al.
Scientific Reports|May 10, 2017
Suppression of autoimmune demyelinating disease by preferential stimulation of CNS-specific CD8 T cells using Listeria-encoded neuroantigenFarah R Itani, Sushmita Sinha, Ashley A Brate, et al.
Clinical Immunology (Orlando, Fla.)|May 8, 2016
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosisImran H Mohiuddin, Vinodh Pillai, Ethan J Baughman, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2014
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cellsKhrishen Cunnusamy, Ethan J Baughman, Jorge Franco, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Plos One|August 28, 2020
Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cellsSushmita Sinha, Pranav S Renavikar, Michael P Crawford, et al.
Journal of Neuroinflammation|November 10, 2010
Characterization of human platelet binding of recombinant T cell receptor ligandAsako Itakura, Joseph E Aslan, Sushmita Sinha, et al.
Scientific Reports|October 20, 2018
An autoimmune disease risk SNP, rs2281808, in SIRPG is associated with reduced expression of SIRPγ and heightened effector state in human CD8 T-cellsSushmita Sinha, Nicholas Borcherding, Pranav S Renavikar, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|November 16, 2020
IL-12-Induced Immune Suppressive Deficit During CD8+ T-Cell DifferentiationPranav S Renavikar, Sushmita Sinha, Ashley A Brate, et al.
Scientific Reports|May 10, 2017
Suppression of autoimmune demyelinating disease by preferential stimulation of CNS-specific CD8 T cells using Listeria-encoded neuroantigenFarah R Itani, Sushmita Sinha, Ashley A Brate, et al.
Clinical Immunology (Orlando, Fla.)|May 8, 2016
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosisImran H Mohiuddin, Vinodh Pillai, Ethan J Baughman, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2014
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cellsKhrishen Cunnusamy, Ethan J Baughman, Jorge Franco, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Plos One|August 28, 2020
Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cellsSushmita Sinha, Pranav S Renavikar, Michael P Crawford, et al.
Journal of Neuroinflammation|November 10, 2010
Characterization of human platelet binding of recombinant T cell receptor ligandAsako Itakura, Joseph E Aslan, Sushmita Sinha, et al.
Scientific Reports|October 20, 2018
An autoimmune disease risk SNP, rs2281808, in SIRPG is associated with reduced expression of SIRPγ and heightened effector state in human CD8 T-cellsSushmita Sinha, Nicholas Borcherding, Pranav S Renavikar, et al.
Pageof 4